2024
DOI: 10.3390/s24072031
|View full text |Cite
|
Sign up to set email alerts
|

Development, Validation, and Comparison of a Novel Nociception/Anti-Nociception Monitor against Two Commercial Monitors in General Anesthesia

Clara M. Ionescu,
Dana Copot,
Erhan Yumuk
et al.

Abstract: In this paper, we present the development and the validation of a novel index of nociception/anti-nociception (N/AN) based on skin impedance measurement in time and frequency domain with our prototype AnspecPro device. The primary objective of the study was to compare the Anspec-PRO device with two other commercial devices (Medasense, Medstorm). This comparison was designed to be conducted under the same conditions for the three devices. This was carried out during total intravenous anesthesia (TIVA) by invest… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 51 publications
0
1
0
Order By: Relevance
“…MAP was monitored in mmHg using a hemodynamics monitor (GE HealthCare, Chicago, IL, USA). The primary objective outcome of this clinical study has been published in [19]. The biometrics of the 70 patients are detailed in Appendix B, and the variability in MAP among these patients is discussed in Appendix C.…”
Section: Clinical Trial Protocolmentioning
confidence: 99%
“…MAP was monitored in mmHg using a hemodynamics monitor (GE HealthCare, Chicago, IL, USA). The primary objective outcome of this clinical study has been published in [19]. The biometrics of the 70 patients are detailed in Appendix B, and the variability in MAP among these patients is discussed in Appendix C.…”
Section: Clinical Trial Protocolmentioning
confidence: 99%